Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2012, Article ID 171636, 11 pages
http://dx.doi.org/10.1155/2012/171636
Review Article

Neural and Molecular Features on Charcot-Marie-Tooth Disease Plasticity and Therapy

1Unidad de Genética y Medicina Molecular, Instituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas (CSIC), Jaume Roig 11, 46010 Valencia, Spain
2CIBER de Enfermedades Raras (CIBERER), ISCIII, 46010 Valencia, Spain
3Faculty of Medicine, University of Castilla-La Mancha, 13071 Ciudad Real, Spain

Received 2 March 2012; Accepted 16 April 2012

Academic Editor: Laurie Doering

Copyright © 2012 Paula Juárez and Francesc Palau. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Skre, “Genetic and clinical aspects of Charcot Marie Tooth's disease,” Clinical Genetics, vol. 6, no. 2, pp. 98–118, 1974. View at Google Scholar · View at Scopus
  2. O. Combarros, J. Calleja, J. M. Polo, and J. Berciano, “Prevalence of hereditary motor and sensory neuropathy in Cantabria,” Acta Neurologica Scandinavica, vol. 75, no. 1, pp. 9–12, 1987. View at Google Scholar · View at Scopus
  3. J. R. Lupski and C. A. Garcia, “Charcot-Marie-Tooth peripheral neuropathies and related disorders,” in The Metabolic and Molecular Bases of Inherited Disease, C. R. Scriver, A. L. Beaudet, W. S. Sly et al., Eds., pp. 5759–5788, McGraw-Hill, New York, NY, USA, 8th edition, 2000. View at Google Scholar
  4. K. Szigeti and J. R. Lupski, “Hereditary motor and sensory neuropathies,” in Emory and Rimoin’s Principles and Practice of Medical Genetics, R. L. Rimoin, J. M. Connor, R. E. Pyeritz, and B. R. Korf, Eds., pp. 2946–2962, Churchill Livingstone Elsevier, Philadelphia, Pa, USA, 5th edition, 2007. View at Google Scholar
  5. A. Patzkó and M. E. Shy, “Update on Charcot-Marie-Tooth disease,” Current Neurology and Neuroscience Reports, vol. 11, no. 1, pp. 78–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K. M. Krajewski, R. A. Lewis, D. R. Fuerst et al., “Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A,” Brain, vol. 123, no. 7, pp. 1516–1527, 2000. View at Google Scholar · View at Scopus
  7. D. Pareyson, V. Scaioli, and M. Laurà, “Clinical and electrophysiological aspects of charcot-marie-tooth disease,” NeuroMolecular Medicine, vol. 8, no. 1-2, pp. 3–22, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. S. Scherer and L. Wrabetz, “Molecular mechanisms of inherited demyelinating neuropathies,” Glia, vol. 56, no. 14, pp. 1578–1589, 2008. View at Google Scholar · View at Scopus
  9. R. Mirsky and K. R. Jessen, “The neurobiology of Schwann cells,” Brain Pathology, vol. 9, no. 2, pp. 293–311, 1999. View at Google Scholar · View at Scopus
  10. H. Webster and F. De, “Development of peripheral nerve fibres,” in Peripheral Neuropathy, P. J. Dyck, P. K. Thomas, J. W. Griffin, P. A. Low, and J. F. Poduslo, Eds., pp. 243–266, WB Saunders, Philadelphia, Pa, USA, 3th edition, 1993. View at Google Scholar
  11. G. Corfas, M. O. Velardez, C. P. Ko, N. Ratner, and E. Peles, “Mechanisms and roles of axon-Schwann cell interactions,” Journal of Neuroscience, vol. 24, no. 42, pp. 9250–9260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Corfas, K. M. Rosen, H. Aratake, R. Krauss, and G. D. Fischbach, “Differential expression of ARIA isoforms in the rat brain,” Neuron, vol. 14, no. 1, pp. 103–115, 1995. View at Google Scholar · View at Scopus
  13. D. Meyer and C. Birchmeier, “Multiple essential functions of neuregulin in development,” Nature, vol. 378, no. 6555, pp. 386–390, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. J. R. Perlin, M. E. Lush, W. Z. Stephens, T. Piotrowski, and W. S. Talbot, “Neuronal Neuregulin 1 type III directs Schwann cell migration,” Development, vol. 138, pp. 4639–4648, 2011. View at Google Scholar
  15. S. De Waegh and S. T. Brady, “Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for schwann cell-axon interactions,” Journal of Neuroscience, vol. 10, no. 6, pp. 1855–1865, 1990. View at Google Scholar · View at Scopus
  16. C. Massicote and S. S. Scherer, “Neuropathies-translating causes into treatments,” in Neuroscience, Molecular Medicine, and the Therapeutic Transformation of Neurology, S. G. Waxman, Ed., pp. 401–414, Elsevier Science, London, UK, 2004. View at Google Scholar
  17. M. E. Shy, “Biology of peripheral inherited neuropathies: schwann cell axonal interactions,” Advances in Experimental Medicine and Biology, vol. 652, pp. 171–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Züchner and J. M. Vance, “Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies,” Nature Clinical Practice Neurology, vol. 2, no. 1, pp. 45–53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Sevilla, T. Jaijo, D. Nauffal et al., “Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy,” Brain, vol. 131, no. 11, pp. 3051–3061, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Pareyson and C. Marchesi, “Diagnosis, natural history, and management of Charcot-Marie-Tooth disease,” The Lancet Neurology, vol. 8, no. 7, pp. 654–667, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Berciano, A. García, E. Gallardo, C. Ramón, and O. Combarros, “Phenotype and clinical evolution of charcot-marie-tooth disease type 1A duplication,” Advances in Experimental Medicine and Biology, vol. 652, pp. 183–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. R. Lupski, R. M. de Oca-Luna, S. Slaugenhaupt et al., “DNA duplication associated with Charcot-Marie-Tooth disease type 1A,” Cell, vol. 66, no. 2, pp. 219–232, 1991. View at Google Scholar · View at Scopus
  23. P. Raeymaekers, V. Timmerman, E. Nelis et al., “Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a),” Neuromuscular Disorders, vol. 1, no. 2, pp. 93–97, 1991. View at Publisher · View at Google Scholar · View at Scopus
  24. P. F. Chance, M. K. Alderson, K. A. Leppig et al., “DNA deletion associated with hereditary neuropathy with liability to pressure palsies,” Cell, vol. 72, no. 1, pp. 143–151, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. P. F. Chance, N. Abbas, M. W. Lensch et al., “Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17,” Human Molecular Genetics, vol. 3, no. 2, pp. 223–228, 1994. View at Google Scholar · View at Scopus
  26. G. A. Nicholson, L. J. Valentijn, A. K. Cherryson et al., “A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies,” Nature Genetics, vol. 7, no. 1, p. 113, 1994. View at Google Scholar · View at Scopus
  27. S. Bort, E. Nelis, V. Timmerman et al., “Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies,” Human Genetics, vol. 99, no. 6, pp. 746–754, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. J. R. Lupski and P. F. Chance, “Hereditary motor and sensory neuropathies involving altered dosage or mutation of PMP22: the CMT1A duplication and HNPP deletion,” in Peripheral Neuropathy, P. L. Dyck and P. K. Thomas, Eds., pp. 1659–1680, Elsevier Saunders, Philadelphia, Pa, USA, 4th edition, 2005. View at Google Scholar
  29. J. Infante, A. García, O. Combarros et al., “Diagnostic strategy for familial and sporadic cases of neuropathy associated with 17p11.2 deletion,” Muscle and Nerve, vol. 24, no. 9, pp. 1149–1155, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Fortun, J. C. Go, J. Li, S. A. Amici, W. A. Dunn Jr., and L. Notterpek, “Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression,” Neurobiology of Disease, vol. 22, no. 1, pp. 153–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Fortun, W. A. Dunn Jr., S. Joy, J. Li, and L. Notterpek, “Emerging Role for Autophagy in the Removal of Aggresomes in Schwann Cells,” Journal of Neuroscience, vol. 23, no. 33, pp. 10672–10680, 2003. View at Google Scholar · View at Scopus
  32. J. Fortun, J. D. Verrier, J. C. Go, I. Madorsky, W. A. Dunn Jr., and L. Notterpek, “The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones,” Neurobiology of Disease, vol. 25, no. 2, pp. 252–265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Aldkofer, R. Naef, and U. Suter, “Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele,” Journal of Neuroscience Research, vol. 49, pp. 671–680, 1997. View at Google Scholar
  34. E. H. Eylar, K. Uyemura, S. W. Brostoff et al., “Proposed nomenclature for PNS myelin proteins,” Neurochemical Research, vol. 4, no. 2, pp. 289–293, 1979. View at Google Scholar · View at Scopus
  35. S. Greenfield, S. Brostoff, E. H. Eylar, and P. Morell, “Protein composition of myelin of the peripheral nervous system,” Journal of Neurochemistry, vol. 20, no. 4, pp. 1207–1216, 1973. View at Google Scholar · View at Scopus
  36. M. E. Shy, A. Jáni, K. Krajewski et al., “Phenotypic clustering in MPZ mutations,” Brain, vol. 127, no. 2, pp. 371–384, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. K. A. Nave, M. W. Sereda, and H. Ehrenreich, “Mechanisms of disease: inherited demyelinating neuropathies—From basic to clinical research,” Nature Clinical Practice Neurology, vol. 3, no. 8, pp. 453–464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Pennuto, E. Tinelli, M. Malaguti et al., “Ablation of the UPR-Mediator CHOP Restores MotorFunction and Reduces Demyelination inCharcot-Marie-Tooth 1B Mice,” Neuron, vol. 57, no. 3, pp. 393–405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. H. Maeda, J. Mitsui, B. W. Soong, Y. Takahashi et al., “Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease,” Annals of Neurology, vol. 71, pp. 84–92, 2012. View at Google Scholar
  40. D. Pareyson, “Axonal Charcot-Marie-Tooth disease: the fog is only slowly lifting,” Neurology, vol. 68, no. 20, pp. 1649–1650, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Verhoeven, K. G. Claeys, S. Züchner et al., “MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2,” Brain, vol. 129, no. 8, pp. 2093–2102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. D. C. Chan, “Dissecting mitochondrial fusion,” Developmental Cell, vol. 11, no. 5, pp. 592–594, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Okamoto and J. M. Shaw, “Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes,” Annual Review of Genetics, vol. 39, pp. 503–536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. O. M. De Brito and L. Scorrano, “Mitofusin 2 tethers endoplasmic reticulum to mitochondria,” Nature, vol. 456, no. 7222, pp. 605–610, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Bach, S. Pich, F. X. Soriano et al., “Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism: a novel regulatory mechanism altered in obesity,” Journal of Biological Chemistry, vol. 278, no. 19, pp. 17190–17197, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Zhao, J. Takita, Y. Tanaka et al., “Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ,” Cell, vol. 105, no. 5, pp. 587–597, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Chen, J. M. McCaffery, and D. C. Chan, “Mitochondrial fusion protects against neurodegeneration in the cerebellum,” Cell, vol. 130, no. 3, pp. 548–562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. S. A. Detmer and D. C. Chan, “Functions and dysfunctions of mitochondrial dynamics,” Nature Reviews Molecular Cell Biology, vol. 8, no. 11, pp. 870–879, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. S. A. Detmer, C. V. Velde, D. W. Cleveland, and D. C. Chan, “Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A,” Human Molecular Genetics, vol. 17, no. 3, pp. 367–375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Cartoni, E. Arnaud, J. J. Médard et al., “Expression of mitofusin 2R94Q in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A,” Brain, vol. 133, no. 5, pp. 1460–1469, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Misko, S. Jiang, I. Wegorzewska, J. Milbrandt, and R. H. Baloh, “Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex,” Journal of Neuroscience, vol. 30, no. 12, pp. 4232–4240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. J. R. Lupski, “Axonal Charcot-Marie-Tooth disease and the neurofilament light gene (NF- L),” American Journal of Human Genetics, vol. 67, no. 1, pp. 8–10, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. B. J. Gentil, S. Minotti, M. Beange, R. H. Baloh, J. P. Julien, and H. D. Durham, “Normal role of the low-molecular-weight neurofilament protein in mitochondrial dynamics and disruption in Charcot-Marie-Tooth disease,” The FASEB Journal, vol. 26, no. 3, pp. 1194–1203, 2011. View at Publisher · View at Google Scholar
  54. F. Dequen, M. Filali, R. C. Larivière, R. Perrot, S. I. Hisanaga, and J. P. Julien, “Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-Tooth disease type 2E,” Human Molecular Genetics, vol. 19, no. 13, pp. 2616–2629, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. F. Hahn, W. F. Brown, W. J. Koopman, and T. E. Feasby, “X-linked dominant hereditary motor and sensory neuropathy,” Brain, vol. 113, no. 5, pp. 1511–1525, 1990. View at Google Scholar · View at Scopus
  56. J. Bergoffen, S. S. Scherer, S. Wang et al., “Connexin mutations in X-linked Charcot-Marie-Tooth disease,” Science, vol. 262, no. 5142, pp. 2039–2042, 1993. View at Google Scholar · View at Scopus
  57. A. Vital, X. Ferrer, A. Lagueny et al., “Histopathological features of X-linked Charcot-Marie-Tooth disease in 8 patients from 6 families with different connexin32 mutations,” Journal of the Peripheral Nervous System, vol. 6, no. 2, pp. 79–84, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Anzini, D. H.-H. Neuberg, M. Schachner et al., “Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32,” Journal of Neuroscience, vol. 17, no. 12, pp. 4545–4551, 1997. View at Google Scholar · View at Scopus
  59. R. V. Baxter, K. B. Othmane, J. M. Rochelle et al., “Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21,” Nature Genetics, vol. 30, no. 1, pp. 21–22, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Cuesta, L. Pedrola, T. Sevilla et al., “The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease,” Nature Genetics, vol. 30, no. 1, pp. 22–25, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Claramunt, L. Pedrola, T. Sevilla et al., “Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect,” Journal of Medical Genetics, vol. 42, no. 4, pp. 358–365, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Marco, A. Cuesta, L. Pedrola, F. Palau, and I. Marín, “Evolutionary and structural analyses of GDAP1, involved in Charcot-Marie-Tooth disease, characterize a novel class of glutathione transferase-related genes,” Molecular Biology and Evolution, vol. 21, no. 1, pp. 176–187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Pedrola, A. Espert, X. Wu, R. Claramunt, M. E. Shy, and F. Palau, “GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria,” Human Molecular Genetics, vol. 14, no. 8, pp. 1087–1094, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Pedrola, A. Espert, T. Valdés-Sánchez et al., “Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease,” Journal of Cellular and Molecular Medicine, vol. 12, no. 2, pp. 679–689, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Niemann, M. Ruegg, V. La Padula, A. Schenone, and U. Suter, “Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease,” Journal of Cell Biology, vol. 170, no. 7, pp. 1067–1078, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Palau, A. Estela, D. Pla-Martín, and M. Sánchez-Piris, “The role of mitochondrial network dynamics in the pathogenesis of charcot-marie-tooth disease,” Advances in Experimental Medicine and Biology, vol. 652, pp. 129–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Niemann, K. M. Wagner, M. Ruegg, and U. Suter, “GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance,” Neurobiology of Disease, vol. 36, no. 3, pp. 509–520, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Estela, D. Pla-Martín, M. Sánchez-Piris, H. Sesaki, and F. Palau, “The Charcot-Marie-Tooth related gene GDAP1 complements cell cycle delay at G2/M in S. cerevisiae fis1 defective cells,” Journal of Biological Chemistry, vol. 286, pp. 36777–36786, 2011. View at Google Scholar
  69. L. Kalaydjieva, H. Lochmüller, I. Tournev et al., “125th ENMC International Workshop: Neuromuscular disorders in the Roma (Gypsy) population, p. 23, April 2004, Naarden, The Netherlands,” Neuromuscular Disorders, vol. 15, no. 1, pp. 65–71, 2005. View at Google Scholar
  70. J. Colomer, R. Gooding, D. Angelicheva et al., “Clinical spectrum of CMT4C disease in patients homozygous for the p.Arg1109X mutation in SH3TC2,” Neuromuscular Disorders, vol. 16, no. 7, pp. 449–453, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Claramunt, T. Sevilla, V. Lupo et al., “The p.R1109X mutation in SH3TC2 gene is predominant in Spanish Gypsies with Charcot-Marie-Tooth disease type 4,” Clinical Genetics, vol. 71, no. 4, pp. 343–349, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. E. Arnaud, J. Zenker, A. S. de Preux Charles et al., “SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 41, pp. 17528–17533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. V. Lupo, M. I. Galindo, D. Martínez-Rubio et al., “Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type 4C affect its localization in the plasma membrane and endocytic pathway,” Human Molecular Genetics, vol. 18, no. 23, pp. 4603–4614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. R. C. Roberts, A. A. Peden, F. Buss et al., “Mistargeting of SH3TC2 away from the recycling endosome causes Charcot-Marie-Tooth disease type 4C,” Human Molecular Genetics, vol. 19, no. 6, pp. 1009–1018, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Stendel, A. Roos, H. Kleine et al., “SH3TC2, a protein mutant in Charcot-Marie-Tooth neuropathy, links peripheral nerve myelination to endosomal recycling,” Brain, vol. 133, no. 8, pp. 2462–2474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. R. H. Baloh, “Mitochondrial dynamics and peripheral neuropathy,” Neuroscientist, vol. 14, no. 1, pp. 12–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. Z. Sahenk, “Neurotrophins and peripheral neuropathies,” Brain Pathology, vol. 16, no. 4, pp. 311–319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. P. N. Hoffman and R. J. Lasek, “Axonal transport of the cytoskeleton in regenerating motor neurons: constancy and change,” Brain Research, vol. 202, no. 2, pp. 317–333, 1980. View at Publisher · View at Google Scholar · View at Scopus
  79. I. G. McQuarrie and R. J. Lasek, “Transport of cytoskeletal elements from parent axons into regenerating daughter axons,” Journal of Neuroscience, vol. 9, no. 2, pp. 436–446, 1989. View at Google Scholar · View at Scopus
  80. P. Verma, S. Chierzi, A. M. Codd et al., “Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration,” Journal of Neuroscience, vol. 25, no. 2, pp. 331–342, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. D. E. Willis and J. L. Twiss, “The evolving roles of axonally synthesized proteins in regeneration,” Current Opinion in Neurobiology, vol. 16, no. 1, pp. 111–118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. X. Navarro, M. Vivó, and A. Valero-Cabré, “Neural plasticity after peripheral nerve injury and regeneration,” Progress in Neurobiology, vol. 82, no. 4, pp. 163–201, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Perea, A. Robertson, T. Tolmachova et al., “Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A,” Human Molecular Genetics, vol. 10, no. 10, pp. 1007–1018, 2001. View at Google Scholar · View at Scopus
  84. E. Passage, J. C. Norreel, P. Noack-Fraissignes et al., “Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease,” Nature Medicine, vol. 10, no. 4, pp. 396–401, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. F. Kaya, S. Belin, P. Bourgeois, J. Micaleff, O. Blin, and M. Fontés, “Ascorbic acid inhibits PMP22 expression by reducing cAMP levels,” Neuromuscular Disorders, vol. 17, no. 3, pp. 248–253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. D. Pareyson, M. M. Reilly, A. Schenone et al., “Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial,” The Lancet Neurology, vol. 10, no. 4, pp. 320–328, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. F. Désarnaud, A. N. Do Thi, A. M. Brown et al., “Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells,” Journal of Neurochemistry, vol. 71, no. 4, pp. 1765–1768, 1998. View at Google Scholar · View at Scopus
  88. M. W. Sereda, G. Meyer zu Hörste, U. Suter, N. Uzma, and K. A. Nave, “Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A),” Nature Medicine, vol. 9, no. 12, pp. 1533–1537, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. G. M. zu Horste, T. Prukop, D. Liebetanz, W. Mobius, K. A. Nave, and M. W. Sereda, “Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy,” Annals of Neurology, vol. 61, no. 1, pp. 61–72, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Khajavi, K. Shiga, W. Wiszniewski et al., “Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy,” American Journal of Human Genetics, vol. 81, no. 3, pp. 438–453, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. C. d'Ydewalle, J. Krishnan, D. M. Chiheb et al., “HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease,” Nature Medicine, vol. 17, no. 8, pp. 968–974, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. E. Soragni, C. Xu, A. Cooper, H. L. Plasterer, J. R. Rusche, and J. M. Gottesfeld, “Evaluation of histone deacetylase inhibitors as therapeutics for neurodegenerative diseases Methods,” Molecular Biology, vol. 793, pp. 495–508, 2011. View at Google Scholar
  93. E. Verdú and X. Navarro, “The role of Schwann cell in nerve regeneration,” in Understanding Glial Cells, B. Castellano, B. González, and M. Nieto Sampedro, Eds., pp. 319–359, Kluwer Academic, Boston, Mass, USA, 1998. View at Google Scholar
  94. L. E. Chen, K. Liu, A. V. Seaber, S. Katragadda, C. Kirk, and J. R. Urbaniak, “Recombinant human Glial growth factor 2 (rhGGF 2) improves functional recovery of crushed peripheral nerve (a double-blind study),” Neurochemistry International, vol. 33, no. 4, pp. 341–351, 1998. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Birchmeier and K. A. Nave, “Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation,” Glia, vol. 56, no. 14, pp. 1491–1497, 2008. View at Google Scholar · View at Scopus
  96. J. Newbern and C. Birchmeier, “Nrg1/ErbB signaling networks in Schwann cell development and myelination,” Seminars in Cell and Developmental Biology, vol. 21, no. 9, pp. 922–928, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. Z. Sahenk, H. N. Nagaraja, B. S. McCracken et al., “NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients,” Neurology, vol. 65, no. 5, pp. 681–689, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Bibel and Y. A. Barde, “Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system,” Genes and Development, vol. 14, no. 23, pp. 2919–2937, 2000. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Funakoshi, M. Risling, T. Carlstedt et al., “Targeted expression of a multifunctional chimeric neurotrophin in the lesioned sciatic nerve accelerates regeneration of sensory and motor axons,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 5269–5274, 1998. View at Publisher · View at Google Scholar · View at Scopus
  100. K. Haastert and C. Grothe, “Gene therapy in peripheral nerve reconstruction approaches,” Current Gene Therapy, vol. 7, no. 3, pp. 221–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Zacchigna and M. Giacca, “Chapter 20 gene therapy perspectives for nerve repair,” International Review of Neurobiology, vol. 87, pp. 381–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. J. Homs, L. Ariza, G. Pagès et al., “Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration,” Gene Therapy, vol. 18, no. 6, pp. 622–630, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Kirchmair, A. B. Tietz, E. Panagiotou et al., “Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF,” Molecular Therapy, vol. 15, no. 1, pp. 69–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Sanchez-Ramos, S. Song, F. Cardozo-Pelaez et al., “Adult bone marrow stromal cells differentiate into neural cells in vitro,” Experimental Neurology, vol. 164, no. 2, pp. 247–256, 2000. View at Publisher · View at Google Scholar · View at Scopus
  105. L. E. Kokai, J. P. Rubin, and K. G. Marra, “The potential of adipose-derived adult stem cells as a source of neuronal progenitor cells,” Plastic and Reconstructive Surgery, vol. 116, no. 5, pp. 1453–1460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  106. J. Caddick, P. J. Kingham, N. J. Gardiner, M. Wiberg, and G. Terenghi, “Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage,” Glia, vol. 54, no. 8, pp. 840–849, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Tohill, C. Mantovani, M. Wiberg, and G. Terenghi, “Rat bone marrow mesenchymal stem cells express Glial markers and stimulate nerve regeneration,” Neuroscience Letters, vol. 362, no. 3, pp. 200–203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. G. Keilhoff, A. Goihl, K. Langnäse, H. Fansa, and G. Wolf, “Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells,” European Journal of Cell Biology, vol. 85, no. 1, pp. 11–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. K. M. Safford, K. C. Hicok, S. D. Safford et al., “Neurogenic differentiation of murine and human adipose-derived stromal cells,” Biochemical and Biophysical Research Communications, vol. 294, no. 2, pp. 371–379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  110. P. A. Zuk, M. Zhu, P. Ashjian et al., “Human adipose tissue is a source of multipotent stem cells,” Molecular Biology of the Cell, vol. 13, no. 12, pp. 4279–4295, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. P. J. Kingham, D. F. Kalbermatten, D. Mahay, S. J. Armstrong, M. Wiberg, and G. Terenghi, “Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro,” Experimental Neurology, vol. 207, no. 2, pp. 267–274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. C. Mantovani, D. Mahay, M. Kingham, G. Terenghi, S. G. Shawcross, and M. Wiberg, “Bone marrow- and adipose-derived stem cells show expression of myelin mRNAs and proteins,” Regenerative Medicine, vol. 5, no. 3, pp. 403–410, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. P. G. Di Summa, P. J. Kingham, W. Raffoul, M. Wiberg, G. Terenghi, and D. F. Kalbermatten, “Adipose-derived stem cells enhance peripheral nerve regeneration,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 63, no. 9, pp. 1544–1552, 2010. View at Publisher · View at Google Scholar · View at Scopus